Navigation Links
Generex Confirms Conference Call with Members of the Antigen Express Scientific Advisory Board
Date:7/23/2013

WORCESTER, Mass. and TORONTO, July 23, 2013 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCBB: GNBT) today confirmed that it will be hosting a conference call with members of the Antigen Express, Inc. (www.antigenexpress.com) Scientific Advisory Board on Wednesday, August 14, 2013 at 10 a.m. EDT.  Call-in particulars will be announced prior to the call.

The call will include a discussion of the on-going Phase II clinical trial of the Antigen Express AE37 breast cancer vaccine and the Antigen Express Ii-Key technology platform in the context of current breast cancer treatments and the industry focus on immunotherapeutic approaches to the treatment of cancer, as highlighted at the June 2013 Annual Meeting of the American Society of Clinical Oncology (ASCO).

The call will feature the following members of the Antigen Express Scientific Advisory Board:

  • Dr.Gary H. Lyman, MD, MPH, FACP, FRCP (Edin), FASCO;
  • Dr. Gabriel N. Hortobagyi, MD, FACP;
  • Dr. Ian Krop, MD, PhD;
  • Dr. Keith L. Knutson, PhD;
  • Dr. James J. Mule, PhD;
  • Dr. Hope S. Rugo, MD; and
  • Dr. Samuel Jacobs, MD.

In addition, Dr. Elizabeth Mittendorf, MD, PhD, the Principal Investigator on the Antigen Express AE37 breast cancer vaccine Phase II trial, will participate on the panel.

"We are pleased to bring together this panel of key opinion leaders to share their insights into the burgeoning research on immunotherapeutic approaches to the treatment of cancer, where scientists are
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Generex Announces Particulars of Conference Call with Members of the Antigen Express Scientific Advisory Board
2. Generex Announces Scheduling of USFDA End-of-Phase II Meeting for the AE37 Breast Cancer Vaccine
3. Generex Enhances Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine with Renowned Breast Cancer Researchers
4. Generex Announces Date of Annual Stockholders Meeting
5. Generex Subsidiary Antigen Express Announces Press Conference at American Association for Cancer Research Related to the Immunological Response of its AE37 Vaccine to Prevent Recurrence of Breast Cancer
6. Generex Announces Patent Award for its Core Vaccine Technologies in Japan
7. Generex Secures Commitments for $3.6M Capital Raise
8. Generex Subsidiary Antigen Express Provides Update on AE37 Cancer Vaccines Clinical & Regulatory Strategy
9. Breast Cancer Vaccine Being Developed by Generex Subsidiary Antigen Express to be Featured on Bloomberg Television Today
10. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
11. Generex Provides Update on Generex Oral-lyn™ Clinical & Regulatory Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Pa. , July 30, 2015  Discovery ... that it has received the second $1.0M tranche ... Innovation Research (SBIR) grant valued at up to ... company,s aerosolized KL4 surfactant as a potential medical ... injury.  Discovery Labs was awarded an initial $1.0 ...
(Date:7/29/2015)... -- According to a new market research report, ... (2015-2020), , published by Mordor Intelligence, the Global market is ... of 2020, with North America being ... the global market size. The Global market for Stem Cells ... the period of (2015-2020).      (Logo: http://photos.prnewswire.com/prnh/20150428/740799) , ...
(Date:7/29/2015)...  AsureQuality and Ubiquitome have agreed to collaborate ... food and primary production sectors. The collaboration will ... the Freedom4. AsureQuality provides quality assurance ... shelf for producers, processors and Competent Authorities around ... control and pest management and surveillance programmes. ...
(Date:7/29/2015)... NEW YORK , July 29, 2015 /PRNewswire/ ... neuropathology testing, announces increased partnerships with VA and ... offers Epidermal Nerve Fiber Density (ENFD) and Sweat ... of small fiber neuropathy ( https://therapath.com/skin ). ... Epidermal Nerve Fiber Density (ENFD) on punch skin ...
Breaking Biology Technology:Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 2Asia Pacific to Dominate the Global Stem Cell Market - Vericel Corporation, Ocata Therpeutics, Athersys Inc., Cryo-Cell International, Geron Corporation, StemCells, Inc. Among the Major Players 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Neuropathology services for VA and Military health systems 2
... Calif. , May 19 ChemoCentryx, Inc., ... the Company,s President and Chief Executive Officer is a ... Year® 2010 Award in Northern California .  According ... entrepreneurs who demonstrate extraordinary success in the areas of ...
... May 19 Hothead Technologies, Inc. and Sivix ... key computing fob and associated sensor monitoring module to ... are based upon the H.O.T.™ System, a patent-pending system ... of an athlete, firefighter, soldier, or other personnel and ...
... N.J. , May 19 Soligenix, Inc. ... late-stage biopharmaceutical company, announced today that the United States ... entitled "Treatment of Irritable Bowel Syndrome and Related Bowel ... (BDP) to treat irritable bowel syndrome (IBS), a painful ...
Cached Biology Technology:ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 2ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 3ChemoCentryx President and CEO, Thomas J. Schall, Ph.D., Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist in Northern California 4Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line 2Hothead Technologies Partners with Sivix Logistics to Add Customized Handheld Monitors and Autonomous Sensors to its Product Line 3Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 2Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 3Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 4Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 5Soligenix Announces Grant of US Patent for the Treatment of Irritable Bowel Syndrome with Oral Beclomethasone Dipropionate 6
(Date:7/7/2015)... 30, 2015 Research ... addition of the "Capacitive Fingerprint Sensors Patent ... To this date, fingerprint sensing technology is the ... sensors are well developed. This patent landscape focuses ... The domain of capacitive fingerprint sensors is ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
(Date:6/30/2015)... NEW YORK , June 30, 2015 To ... biometric security provider HYPR Corp. announced today the addition of ... will serve as board advisor and David Raviv ... to the team underscore HYPR Corp.,s commitment to providing the ... , Dimitri Sirota co-founded Layer 7 Technologies, a ...
Breaking Biology News(10 mins):Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... for Species Exploration at Arizona State University names the Top ... list for 2009 was published to coincide with the 303rd ... It contains only two new plant species, one of which ... Linnean Society . Nepenthes attenboroughii , a ...
... green fluorescent protein known simply as GFP has revolutionized cell ... scientists to visualize proteins inside of cells and track them ... who discovered and developed the protein as a laboratory tool ... GFP as a fluorescent probe has one major drawback ...
... TU Delft and Molecular Imaging Labs (MI Labs) have ... into one piece of equipment. These techniques are particularly ... as microPET and microSPECT. SPECT and PET can be ... traditional microSPECT and microPET. The new device is known ...
Cached Biology News:Rare carnivorous plant on top 10 list of newly discovered species 2MIT chemists design new way to fluorescently label proteins 2TU Delft and MI Labs merge PET and SPECT biomedical imaging techniques and increase resolution 2
Complement C1q subcomponent subunit C precursor. [Source:Uniprot/SWISSPROT;Acc:P02747] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Monoclonal Mouse Anti-Human Cytokeratin 16 (48 kD)...
Mouse monoclonal [CRC64] to Integrin alpha 2b + beta 3 ( Abpromise for all tested applications). Antigen: Human platelets Entrez Gene ID: 23295 Swiss Protein ID: P05106...
PFM8 Antibody...
Biology Products: